Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis.
[cutaneous mastocytosis]
Diffuse
cutaneous
mastocytosis
is
a
less
common
but
potentially
life-threatening
variant
of
childhood
mastocytosis
.
Here
we
report
2
children
with
diffuse
cutaneous
mastocytosis
in
whom
an
activating
somatic
KIT
mutation
was
detected
.
Treatment
with
imatinib
,
a
KIT
inhibitor
,
resulted
in
resolution
of
the
lesions
and
were
well
tolerated
by
the
patients
.